Hepatitis B Pipeline Market and Products Review, H1 2015

Hepatitis B - Pipeline Review, H1 2015 is now available at RnRMarketResearch store. This report provides an overview of the Hepatitis B's therapeutic pipeline.

Hepatitis B is an Infection which affects the liver of human. Hepatitis B does not show any symptoms. If you do, it can make you feel like you have the flu.  This Virus can be passed by the mother to baby during    delivery. Some of the symptoms may also include feeling tired, headache, dark urine and not wanting to eat. This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Get a copy of this report at . (This is a premium report price at US$2000 for a single user PDF license)

Some of the Company profiles mentioned in this report are Benitec Biopharma Limited, Biogenomics Limited, BioStar Pharmaceuticals, Bukwang Pharm.Co., Ltd., Chongqing Zhifei Biological Products Co., Ltd., Dynavax Technologies Corporation, Green Cross Corporation, Jiangsu Hansoh Pharmaceutical Co., Ltd., Ligand Pharmaceuticals, PharmaEssentia Corporation, Spring Bank Pharmaceuticals, TetraLogic Pharmaceuticals, WaterStone Pharmaceuticals.


- The report provides a snapshot of the global therapeutic landscape of Hepatitis B

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Hepatitis B and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Hepatitis B products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.